PULMONARY ARTERIAL HYPERTENSION OF CONGENITAL HEART DISEASE
Clinical trials for PULMONARY ARTERIAL HYPERTENSION OF CONGENITAL HEART DISEASE explained in plain language.
Never miss a new study
Get alerted when new PULMONARY ARTERIAL HYPERTENSION OF CONGENITAL HEART DISEASE trials appear
Sign up with your email to follow new studies for PULMONARY ARTERIAL HYPERTENSION OF CONGENITAL HEART DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug hope for rare Heart-Lung condition: sotatercept trial launches
Disease control Recruiting nowThis study tests whether adding the drug sotatercept to standard care can help adults with pulmonary arterial hypertension (PAH) caused by unrepaired congenital heart defects, including Eisenmenger syndrome. About 36 adults in Japan will be randomly assigned to receive either sot…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION OF CONGENITAL HEART DISEASE
Phase: PHASE4 • Sponsor: Kazuya Hosokawa • Aim: Disease control
Last updated May 26, 2026 03:42 UTC
-
Could your DNA predict lung blood pressure disease?
Knowledge-focused Recruiting nowThis study aims to find genetic factors linked to pulmonary hypertension (high blood pressure in the lungs). Researchers will collect health surveys and saliva samples from 10,000 US adults aged 18 and older, both with and without the condition. Participation is online and takes …
Matched conditions: PULMONARY ARTERIAL HYPERTENSION OF CONGENITAL HEART DISEASE
Sponsor: Rutgers, The State University of New Jersey • Aim: Knowledge-focused
Last updated May 26, 2026 03:40 UTC